Biomedical Engineering Reference
In-Depth Information
Buval'tsev VI, Spasskaia MB, Nebieridze DV, et al. Pharmacological modulation of NO synthesis
in patients with arterial hypertension and endothelial dysfunction. Klin Med (Mosk)
2003;81:51-5.
Chen Z, Foster MW, Zhang J, et al. An essential role for mitochondrial aldehyde dehydrogenase
in nitroglycerin bioactivation. PNAS 2005;102:12159-12164.
Chung L, Shapiro L, Fiorentino D, et al. MQX-503, a novel formulation of nitroglycerin, improves
the severity of Raynaud's phenomenon: a randomized, controlled trial. Arthritis Rheum
2009;60:870-7.
Cosby K, Partovi KS, Crawford JH, et al. Nitrite reduction to nitric oxide by deoxyhemoglobin
vasodilates the human circulation. Nat Med 2003;9:1498-1505.
de Berrazueta JR, Sampedro I, Garcia-Unzueta MT, et al. Effect of transdermal nitroglycerin on
inflammatory mediators in patients with peripheral atherosclerotic vascular disease. Am Heart
J 2003;146:E14.
Doctor A, Platt R, Sheram ML, et al. Hemoglobin conformation couples erythrocyte S-nitrosothiol
content to O2 gradients. PNAS 2005;102:5709-14.
Flögel U, Fago A, Rassaf T. Keeping the heart in balance: the functional interactions of myoglobin
with nitrogen oxides. J Exp Biol 2010;213:2726-33.
Glueck CJ, Munjal J, Khan A, et al. Endothelial nitric oxide synthase T-786C mutation, a revers-
ible etiology of Prinzmetal's angina pectoris. Am J Cardiol 2010;105:792-6.
Hayashi T, Juliet PA, Matsui-Hirai H, et al. L-citrulline and L-arginine supplementation retards
the progression of high-cholesterol-diet-induced atherosclerosis in rabbits. PNAS
2005;102:13681-6.
Hayashi T, Matsui-Hirai H, Miyazaki-Akita A, et al. Endothelial cellular senescence is inhibited
by nitric oxide: Implications in atherosclerosis associated with menopause and diabetes. PNAS
2006;103:17018-23.
Hendgen-Cotta UB, Shiva S, Merx MW, et al. Nitrite reductase activity of myoglobin regulates
respiration and cellular viability in myocardial ischemia-reperfusion injury. PNAS
2008;105:10256-61.
Howes LG, Brillante DG. Expert opinion on tilarginine in the treatment of shock. Expert Opin
Investig Drugs 2008;17:1573-80.
Jain KK. Nanbiotechnology: applications, markets and companies. Jain PharmaBiotech, Basel,
2011a.
Jain KK. Nitric Oxide: therapeutics, markets & companies. Jain PharmaBiotech, Basel, 2011b.
Kalinowski L, Dobrucki IT, Malinski T. Race-specific differences in endothelial function: predis-
position of African Americans to vascular diseases. Circulation 2004;109:2511-7.
Kaneda H, Taguchi J, Kuwada Y, et al. Coronary artery spasm and the polymorphisms of the
endothelial nitric oxide synthase gene. Circ J 2006;70:409-13.
Kawashima S. Malfunction of Vascular Control in Lifestyle-Related Diseases: Endothelial Nitric
Oxide (NO) Synthase/NO System in Atherosclerosis. J Pharmacol Sci 2004;96:411-9.
Khan SA, Lee K, Minhas KM, et al. Neuronal nitric oxide synthase negatively regulates xanthine
oxidoreductase inhibition of cardiac excitation-contraction coupling. Proc Natl Acad Sci USA
2004;101:15944-8.
Kumar D, Branch BG, Pattillo CB, et al. Chronic sodium nitrite therapy augments ischemia-
induced angiogenesis and arteriogenesis. PNAS 2008;105:7540-45.
Lauer T, Kleinbongard P, Rath J, et al. l-Arginine preferentially dilates stenotic segments of coro-
nary arteries thereby increasing coronary flow. J Int Med 2008;264:237-244.
Lorusso R, De Cicco G, Beghi C, et al. Functional effects of nitric oxide-releasing aspirin on vein
conduits of diabetic patients undergoing CABG NO-aspirin and vein grafts in type-2 diabetes
mellitus. Int J Cardiol 2007;118:164-9.
Malinski T. Understanding nitric oxide physiology in the heart: a nanomedical approach. Am
J Cardiol 2005;96(7B):13i-24i.
Mattagajasingh I, Kim CS, Naqvi A, et al. SIRT1 promotes endothelium-dependent vascular
relaxation by activating endothelial nitric oxide synthase. PNAS 2007;104:14855-60.
Search WWH ::
Custom Search